Wedge resection or enucleation in pulmonary hamartoma?

Dirol Hülya, Keski Hakan
{"title":"Wedge resection or enucleation in pulmonary hamartoma?","authors":"Dirol Hülya, Keski Hakan","doi":"10.5604/01.3001.0015.7878","DOIUrl":null,"url":null,"abstract":"Background: Wedge resection and enucleation are the most commonly preferred surgical modalities for the treatment of pulmonary hamartomas. There is a concern about the safety and efficacy of enucleation for a pulmonary hamartoma.\nAim of the study: To compare wedge resection and enucleation for the surgical treatment of pulmonary hamartomas.\nMaterial and Methods: We retrospectively analyzed the data from patients who were surgically diagnosed with pulmonary hamartoma between January 2014 and December 2019. We obtained data on clinical findings, radiological features, surgical modality, postoperative complications, and follow-up results from the hospital electronic database. We compared all these features in the patients who underwent wedge resection with those who received enucleation.\nResults: A total of 18 patients with pulmonary hamartoma were analyzed. The mean age of the patients was 60.56 ± 9.25 years and 10 (55.6%) were male. Twelve (66.7%) patients had no respiratory symptoms. Ten (55.6%) of the patients underwent wedge resection and 8 (54.4%) patients had enucleation. There were no significant differences in age, gender, symptom distribution, prolonged air leakage, hospital stay length, intensive care unit stay length, mortality, or relapse rate between the patients with wedge resection and enucleation. Nodule size, calcification, metabolic activity, central or peripheral location, and lobar distribution were also similar.\nConclusions: We observed that there were no significant differences in the postoperative complications, hospital stay length, mortality or relapse between the patients with wedge resection and enucleation. Minimal parenchymal damage and resection should be the aim of surgical interventions for benign lung diseases. Therefore, we believe that enucleation should be the first choice for the surgical treatment pulmonary hamartomas.\n\n","PeriodicalId":32604,"journal":{"name":"Medical Science Pulse","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Science Pulse","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5604/01.3001.0015.7878","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Wedge resection and enucleation are the most commonly preferred surgical modalities for the treatment of pulmonary hamartomas. There is a concern about the safety and efficacy of enucleation for a pulmonary hamartoma. Aim of the study: To compare wedge resection and enucleation for the surgical treatment of pulmonary hamartomas. Material and Methods: We retrospectively analyzed the data from patients who were surgically diagnosed with pulmonary hamartoma between January 2014 and December 2019. We obtained data on clinical findings, radiological features, surgical modality, postoperative complications, and follow-up results from the hospital electronic database. We compared all these features in the patients who underwent wedge resection with those who received enucleation. Results: A total of 18 patients with pulmonary hamartoma were analyzed. The mean age of the patients was 60.56 ± 9.25 years and 10 (55.6%) were male. Twelve (66.7%) patients had no respiratory symptoms. Ten (55.6%) of the patients underwent wedge resection and 8 (54.4%) patients had enucleation. There were no significant differences in age, gender, symptom distribution, prolonged air leakage, hospital stay length, intensive care unit stay length, mortality, or relapse rate between the patients with wedge resection and enucleation. Nodule size, calcification, metabolic activity, central or peripheral location, and lobar distribution were also similar. Conclusions: We observed that there were no significant differences in the postoperative complications, hospital stay length, mortality or relapse between the patients with wedge resection and enucleation. Minimal parenchymal damage and resection should be the aim of surgical interventions for benign lung diseases. Therefore, we believe that enucleation should be the first choice for the surgical treatment pulmonary hamartomas.
肺错构瘤是楔形切除还是去核?
背景:楔形切除和摘除是治疗肺错构瘤最常用的手术方式。肺错构瘤摘除术的安全性和有效性一直备受关注。研究目的:比较楔形切除术和摘除术治疗肺错构瘤的疗效。材料和方法:我们回顾性分析了2014年1月至2019年12月期间经手术诊断为肺错构瘤的患者的数据。我们从医院电子数据库中获得了有关临床表现、放射学特征、手术方式、术后并发症和随访结果的数据。我们比较了接受楔形切除术的患者和接受摘除术的患者的所有这些特征。结果:对18例肺错构瘤患者进行分析。患者平均年龄为60.56±9.25岁,男性10例(55.6%)。12例(66.7%)患者无呼吸道症状。其中10例(55.6%)患者行楔形切除术,8例(54.4%)患者行眼球摘除术。楔形切除和摘除患者在年龄、性别、症状分布、长期漏气、住院时间、重症监护室住院时间、死亡率或复发率方面没有显著差异。结节大小、钙化、代谢活动、中心或外周位置以及肺叶分布也相似。结论:我们观察到楔形切除和摘除患者在术后并发症、住院时间、死亡率或复发方面没有显著差异。肺良性疾病的手术干预应以最小的实质损伤和切除为目标。因此,我们认为摘除眼球应是治疗肺错构瘤的首选手术方式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
29
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信